doi:10.2337/db14-1947 44
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
The time of day is ultimately up to you, but we suggest taking your daily eye health+ capsule with a meal or soon after (i.e., within 30 minutes of a meal) to facilitate optimal absorption of the fat-soluble phytonutrient compounds
E., Kanikarla-Marie, P
Adult content, surgery has risks
Antioxidant Capacity: Research into the peptide's ability to inhibit lipid peroxidation and increase the activity of endogenous antioxidant enzymes (SOD, Glutathione Peroxidase)